Project Number EUJPND-Belgium-FIE-JANSSEN PHARMACEUTICA-282 Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Year 2016 View Full Project Details for BBB : Development of a roadmap for assessment of blood-brain barrier drug transport - Translation from rodents to patients Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 11. Vascular Etiology b. BBB and Neurovascular Unit Researcher and Organization Principal Investigator JANSSEN PHARMACEUTICA Principal Investigator First Name JANSSEN PHARMACEUTICA Principal Investigator Last Name JANSSEN PHARMACEUTICA Awardee Organization JANSSEN PHARMACEUTICA Contact PI Country Belgium Project Detail FY Overall Cost $281,052 Funding Organization Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Organization Country Belgium Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
